From miw@fw5.sacserv.com Wed May 4 07:22:31 2005 [2005-05-04 07:22:31 125713]
Received: from mail.sacserv.com (mail.sacserv.com [216.70.30.232])
   by www.munged.ext (8.11.6/8.11.6) with SMTP id j44BMVa03231
   for <chien@munged.ext>; Wed, 4 May 2005 07:22:31 -0400
Received: (qmail 15025 invoked from network); 4 May 2005 11:13:01 -0000
Received: from unknown (HELO mail7.sacserv.com) (127.0.0.1)
   by 0 with SMTP; 4 May 2005 11:13:01 -0000
Message-ID: <86840.1115205181796.JavaMail.miw@localhost>
Date: Wed, 4 May 2005 06:13:01 -0500 (CDT)
From: E-mailNewsService <biomednews@aol.com>
Reply-To: E-mailNewsService <biomednews@aol.com>
To: chien@munged.ext
Subject: BMN PRESS RELEASE: Competitive Acquisition Audioconference To Share
Physician Participation Data, Pharma/Biotech Takeaways For New Medicare
Program
X-Sub-ID: 3412705
X-Camp-ID: 141572

BMN PRESS RELEASE
Contact: Paul Nash
HCPro Inc
781-639-1872 ext 3139 phone
pnash@hcpro.com


COMPETITIVE ACQUISITION AUDIOCONFERENCE TO SHARE PHYSICIAN PARTICIPATION DATA, PHARMA/BIOTECH TAKEAWAYS FOR NEW MEDICARE PROGRAM
-- June 07 2005 -- 90-minute audioconference hosted by ePharmaceuticals, a div of HCPro, Inc.
http://sacserv.com/links.jsp?linkid=19735&subid=3412705&campid=141572&type=0


MARBLEHEAD MA USA -- MEDICAL INDUSTRY E-MAIL NEWS SERVICE(TM) -- MAY 04 2005 -- The competitive acquisition program (CAP), a provision of the Medicare Modernization Act, will shift the financial risk of drug purchasing, billing and delivery, from physicians to specialty pharmacies, when it becomes effective on Jan 01 2006. CAP will pose new threats and opportunities for pharmaceutical and biotech firms, regarding use of injectable and infusible drugs and biologicals.

Learn more about CAP in the 90-minute audioconference, Competitive Acquisition: Analysis & Takeaways for Pharma & Biotech, presented by ePharmaceuticals. The program, which features a 5-person panel, is June 7, at 1 pm EDT - just days after the Centers for Medicare & Medicaid Services is expected to release the final CAP rules.

"The days of treatment without co-payment are probably gone for good, so the CAP - even though the program may initially have a limited scope - could be the future. This is an opportunity for pharma and biotech," says Bryan Cote, Executive Editor of ePharmaceuticals and Moderator of the audioconference. "To capitalize, the industry needs to learn more about how specialty pharmacies will operate under CAP and the potential issues that CAP presents in the delivery of their products."

Under CAP, physicians can select vendors, such as specialty pharmacies, to assume responsibility for drug purchasing, delivery, co-pay collection and distribution. Participating physicians who administer drugs in their offices will no longer bill Medicare directly for the drugs; they will, however, continue to bill Medicare for the administration portion.

During the audioconference, Cote will present exclusive survey data which projects physician participation by specialty. (Participation in CAP is voluntary.)

THE SPEAKER PANEL

The speaker panel includes Kevin Barnett, Sr VP, Campbell Alliance, a pharmaceutical and biotech management consulting firm; Karen Freeman, Executive VP, Biologics Inc., a specialty oncology pharmacy in the US; Thomas Barr, Executive Director of Oncology Metrics and Past-President of the Administrators in Oncology/Hematology Assembly; and Nicholas Opalich, Managing Partner of Strategic Health Partners, LLC.

"This event will focus on physicians' participation in CAP, their understanding of it and the role specialty pharmacies will take," explains Cote. "The CAP is controversial and oncologists are resisting it, but there's interest from other specialties. Pharma and biotech will need to refocus their marketing and sales efforts as a result of CAP."

PROGRAM HIGHLIGHTS

-- Final CAP Rules
<> Key elements of final rules and how they change the drug purchasing/billing landscape
-- Physician Perspective
<> How many physicians will participate in CAP and why
<> Physician perspective on CAP
<> Key data from HCPro survey
-- Role of Specialty Pharmacy under CAP
<> How specialty pharmacies will operate
<> The billing changes and what this means for pharma and biotech
-- Marketing and Sales
<> How marketing and sales must change from a strategic perspective under CAP
-- Live Q&A

WHO SHOULD LISTEN?

Reimbursement analysts and customer planning managers, sales management, brand teams, managed market teams, compliance officers, legal counsel, government contractors, and anyone else in the pharma, biotech and specialty pharmacy industries who is interested in how and where biologicals and injectables are administered - and how they are billed

REGISTRATION:

To participate in Competitive Acquisition: Analysis & Takeaways for Pharma & Biotech, click below:

http://sacserv.com/links.jsp?linkid=19736&subid=3412705&campid=141572&type=0

or call 877-437-4276 and mention Source Code EZ36349A.

ABOUT EPHARMACEUTICALS:

ePharmaceuticals, a division of Marblehead MA-based HCPro, Inc., provides business intelligence, compliance training, market research reports, and custom publishing services to the pharmaceutical industry. Publications include ePharmaceuticals, a daily business and marketing innovation newsletter, Medicare & Reimbursement Advisor Weekly, and Compliance Alert for Drug Sales & Marketing.

Take an online demo of our compliance courses at:

http://sacserv.com/links.jsp?linkid=19737&subid=3412705&campid=141572&type=0

For more about ePharmaceuticals, go to:

http://sacserv.com/links.jsp?linkid=19738&subid=3412705&campid=141572&type=0

FOR FURTHER INFORMATION, PLEASE CONTACT:

Paul Nash
Director, ePharmaceuticals
HCPro, Inc.
200 Hoods Lane
Marblehead MA USA 01945
781-639-1872 ext 3139 phone
781-639-2982 fax
pnash@hcpro.com
http://sacserv.com/links.jsp?linkid=19739&subid=3412705&campid=141572&type=0

Please forward this press release to colleagues who may want to read it.
-----------
EDITOR'S NOTE: The opinions, claims/statements in this press release are solely those of the author. The Medical Industry E-mail News Service(TM) & BMN Inc accept no legal liability/responsibility for its contents/transmission.

According to legal experts & federal requirements, this press release FULLY complies w/the CAN-SPAM Act, each of its provisions, & all applicable/current state/federal laws & regulations. This electronic newsletter & daily news transmittal service are Constitutionally-protected publications. Like the wire services, these are PAID transmittals of a news announcement & newsletter -- not an advertisement -- via the "Medical Industry E-Mail News Service(TM)." It's the world's 1st/largest, press release/newsletter distribution service focused exclusively on the medical product mfg industry.

ADD ME: If you/colleagues want to be added to this comp press release distribution list, please click below, or email: biomednews@aol.com
http://sacserv.com/links.jsp?linkid=19740&subid=3412705&campid=141572&type=0

READERSHIP: Pass-around e-mail forwarding generates a total readership of approx. 300,000-500,000 persons in almost 200 countries. Includes: valuable middle to top mgmt, key execs, decision-makers & regulatory affairs professionals at almost every US medical product mfgr/supplier & medical service provider. Over 800 leading medical trade associations, major universities, medical ctrs/hospitals, medical publishers, medical product mfg/service providers, law firms, regulatory organizations, US Federal Govt, & economic devel organizations, often use our E-mail News Service(TM).

TO ORDER: To place an order to transmit your press release to over 200,000 individual e-mail addresses of medical industry execs worldwide, please contact BMN Inc: jemailnews@aol.com or click below to charge your 1st order:
http://sacserv.com/links.jsp?linkid=19741&subid=3412705&campid=141572&type=0
2770 S Harbor Bl Ste H
Santa Ana CA USA 92704-5835
714-549-4180 phone
jemailnews@aol.com
http://sacserv.com/links.jsp?linkid=19742&subid=3412705&campid=141572&type=0
-----------
Delete/Add/Change Requests: We honor all delete requests. To be removed from this distribution list, or to change/add your email #, please follow the simple instructions below. Or, forward the entire press release to: biomednews@aol.com & type: "Please Delete" in the subjectline. That way we can use computer coding at the tail end to correctly match it to your exact email #. Please allow 1-3 business days to take effect. Not asking to be deleted means that you consent to receive press releases & confirms there is an ongoing business correspondent relationship.

To be removed from future e-mail transmittals, please click on the following link or copy and paste it into your web browser and press the RETURN key.
http://sacserv.com/unsubscribe.jsp?subid=3412705&custid=76&campid=141572

------------------------------------------------------------

link redirects to:
http://www.hcmarketplace.com/prod.cfm?id=3337&s=EZ36349A

Contact our Customer Service Center at 877-727-1728
HCPro, Inc.
200 Hoods Lane
Marblehead, MA 01945 USA
Phone: 877/727-1728
Fax: 800/639-8511
webmaster@hcmarketplace.com
http://www.hcpro.com

------------------------------------------------------------

order link redirects to:
http://www.biomedical-market-news.com/cgi-local/SoftCart.exe/online-store/scstore/p-000000000158.html?E+scstore

Biomedical Market Newsletter
NEWSLETTERS
COMPANY DIRECTORIES
FDA REGULATORY MANUALS
MARKET RESEARCH STUDIES
MAIL LISTS & DATABASES
3237 Idaho Pl - Costa Mesa CA USA 92626-2207
(800) 875-8181 toll free phone
(714) 434-9500 phone
(714) 43409755 fax
http://www.biomedical-market-news.com

http://www.biomedical-market-news.com/cgi-local/SoftCart.exe/online-store/scstore/sitepages/about.html?L+scstore+tmsf5734ff072a07+1117519122
EDITORIAL & CIRCULATION OFFICE:
Biomedical Market Newsletter, Inc.
3237 Idaho Place
Costa Mesa, CA USA 92626-2207
(714) 434-9500 phone
(714) 434-9755 fax
biomednews@aol.com
info@biomedical-market-news.com

SALES OFFICE:
Biomedical Market Newsletter, Inc.
2770 S Harbor Blvd, Ste H
Santa Ana, CA USA 92704-5835
714-549-4180 phone
714-549-4266 fax

Dave Anast Publisher/Editor/CEO (714) 434-9500 phone info@biomedical-market-news.com
Steve Baker Director of Marketing & Sales (714) 435-1824 phone steve@biomedical-market-news.com
John Stone Director of E-mail News Service Sales (714) 549-4180 phone john@biomedical-market-news.com
Richard Guiss Senior Editor (714) 549-4180 phone richard@biomedical-market-news.com
Athey Anast Business Manager (714) 434-9500 phone
George Anast CFO (714) 434-9500 phone

Biomedical Market Newsletter
3237 Idaho Place
Costa Mesa, CA USA 92626-2207
(714) 434-9500 phone
(714) 434-9755 fax
(800) 875-8181 toll free phone (US only)
info@biomedical-market-news.com

------------------------------------------------------------

[whois.networksolutions.com]

Registrant:
HCPro, Inc.
   200 Hoods Lane
   Marblehead, MA 01945
   US

   Domain Name: HCMARKETPLACE.COM

   Administrative Contact, Technical Contact:
      Armitage, Matt            marmitage@hcpro.com
      HCPro, Inc.
      200 Hoods Lane
      Marblehead, MA 01945
      US
      781-639-1872 fax: 781-639-1748

   Record expires on 20-May-2008.
   Record created on 20-May-1999.
   Database last updated on 10-May-2005 11:40:56 EDT.

   Domain servers in listed order:

   PIT.MAXIM.NET                216.65.0.150
   PENDULUM.MAXIM.NET           216.65.0.162

hcmarketplace.com has address 216.65.62.15
www.hcmarketplace.com has address 216.65.62.15

[whois.networksolutions.com]

Registrant:
MIW LLC (SBFWZIBUHD)
   223 West Michigan Street
   Duluth, MN 55802
   US

   Domain Name: SACSERV.COM

   Administrative Contact, Technical Contact:
      MIW LLC  (25884456O)              domains@duluthmn.com
      223 West Michigan Street
      Duluth, MN 55802
      US
      218-722-5000 fax: 218-733-0130

   Record expires on 19-May-2005.
   Record created on 19-Dec-2003.
   Database last updated on 9-May-2005 20:01:54 EDT.

   Domain servers in listed order:
   DNS1.MM-INTERACTIVE.COM      216.70.31.3
   DNS2.MM-INTERACTIVE.COM      216.70.25.3

sacserv.com has address 216.70.30.233
www.sacserv.com has address 216.70.30.233

[whois.networksolutions.com]

Registrant:
Biomedical Market Newsletter
   3237 Idaho Place
   Costa Mesa, CA 92626
   US

   Domain Name: BIOMEDICAL-MARKET-NEWS.COM

   Administrative Contact:
      Isaacs, David             disaacs@mdwtech.com
      MDW Technologies, LLC
      20101 S.W. Birch St.
      Suite 130-D
      NEWPORT BEACH, CA 92660-1748
      US
      949-757-0341 fax: 949-757-0456

   Technical Contact:
      Heuer, Marco              mh3_nsi@MHE.COTSE.NET
      Biomedical Market Newsletter
      3237 Idaho Place
      Costa Mesa, CA 92626
      US
      (714) 434-9500 fax: (714) 662-1167

   Record expires on 10-May-2012.
   Record created on 09-May-1995.
   Database last updated on 9-May-2005 19:59:49 EDT.

   Domain servers in listed order:
   NS19A.NAMESERVERS.NET        161.58.134.98
   NS19B.NAMESERVERS.NET        161.58.134.114

biomedical-market-news.com has address 161.58.146.150
www.biomedical-market-news.com has address 161.58.146.150